Business
Phase One Development of Rapid COVID-19 Point of Care Test Complete 5mo19
Atlanta, GA : Pepex Biomedical, Inc. (the “Company”), a leading developer of enzymatic biosensor technology, has completed the initial development phase of its forthcoming suite of immunosensor testing products designed to accurately identify COVID-19 antigens […]